세계 가정용 수면 무호흡 증후군 장치 시장 예측(2023-2028년)

The home-based sleep apnea devices market is expected to grow at a CAGR of 16.47% from US$1.556 billion in 2021 to US$4.523 billion in 2028.

The home-based sleep apnea devices market has grown significantly in recent years, owing to the increasing prevalence of sleep apnea and greater awareness of its potential health hazards. These cutting-edge technologies provide a simple and non-intrusive way to monitor and diagnose sleep apnea from the comfort of one's own home. These home-based systems can correctly detect sleep disorders and give vital data to healthcare experts by utilising innovative technology such as airflow sensors, pulse oximetry, and wearable gadgets. The growing emphasis on remote patient monitoring and telemedicine has spurred demand for such devices, which provide cost-effective and accessible options for sleep apnea care. As the worldwide population strives for better sleep health, the home-based sleep apnea devices market is expected to expand steadily in the coming years.

Rising Prevalence of Sleep Apnea Enhances the Home-Based Sleep Apnea Devices Market Growth.

The increased prevalence of sleep apnea is a major growth factor in the home-based sleep apnea devices market. A significant proportion of the worldwide population suffers from sleep apnea, a sleep disease characterised by disrupted breathing during sleep. Lifestyle changes, obesity, ageing demographics, and more awareness of sleep problems all contribute to the condition's rising incidence. As a result, there is a rising desire for effective and convenient home-based devices that can monitor and diagnose sleep apnea, allowing people to manage their disease from the convenience of their own homes. Manufacturers and healthcare providers are aggressively investing in developing and marketing such devices in order to meet patients' expanding requirements and alleviate the growing impact of sleep apnea on public health systems.

Technological Advancements in Home-Based Devices in Home-Based Sleep Apnea Devices Market.

Technological developments in home-based sleep apnea devices have been a major driver of market expansion. These advancements have resulted in the creation of more complex and user-friendly devices, making it easier for individuals to control their sleep apnea. Sleep patterns, respiratory events, and oxygen levels may all be monitored accurately and in real time thanks to advanced sensors and algorithms. Furthermore, miniaturisation and wearable technologies have increased the comfort and portability of these gadgets, allowing users to sleep peacefully with them. Integration with smartphones and other smart devices provides smooth data transfer and analysis, providing useful insights to patients and healthcare professionals for personalised treatment programmes. As technology advances, the home-based sleep apnea devices market is projected to see more developments, improving patient outcomes, and encouraging improved sleep health.

Convenience and Non-Intrusive Monitoring Boosts the Home-Based Sleep Apnea Devices Market Size.

The ease of use and non-intrusive monitoring provided by home-based sleep apnea devices have played an important part in their acceptance and market expansion. These gadgets, unlike traditional in-lab sleep studies, allow individuals to track their sleep patterns and respiratory episodes in the privacy of their own homes. This non-intrusive method removes the need for overnight stays in sleep centres, which reduces pain and promotes improved sleep quality. Users can easily wear wearable devices or put non-invasive sensors, eliminating the need for the time-consuming setup of standard sleep monitoring equipment. The incorporation of these devices into daily routines allows for continuous and unobtrusive data collection, providing valuable insights for both patients and healthcare providers to assess sleep quality, detect sleep disorders, and design personalised treatment plans, ultimately improving patient compliance and overall sleep health.

North America is the Market Leader in the Home-Based Sleep Apnea Devices Market.

North America was regarded as the market leader in the home-based sleep apnea devices market. This can be ascribed to a number of variables, including the region's high prevalence of sleep apnea, a well-established healthcare infrastructure, and rising public awareness of sleep disorders. Furthermore, major technology improvements and a favourable regulatory environment in North America have encouraged the introduction of home-based sleep apnea devices. The presence of significant market players, R&D efforts, and the availability of advanced wearable technologies strengthened the region's position as a trailblazer in driving innovations and growth in the home-based sleep apnea devices market.

Demand for Continuous Sleep Health Monitoring in Home-Based Sleep Apnea Devices Market.

The growing acknowledgment of the importance of sleep-in overall well-being is driving the increased need for continuous sleep health monitoring. Individuals are looking for techniques to monitor their sleep habits and identify potential sleep problems as awareness about the influence of sleep on physical and mental health grows. Continuous sleep health monitoring enables for continuous evaluation of sleep quality, respiratory events, and sleep-related indicators, offering a full picture of an individual's sleep health throughout time. Continuous monitoring is provided through home-based sleep apnea devices and wearable technology, allowing users to analyse their sleep patterns, identify sleep interruptions, and make educated decisions to improve their sleep habits. Furthermore, healthcare providers will have access to longitudinal data, which will allow for more accurate diagnosis, personalised therapy, and proactive management of sleep-related illnesses for better patient outcomes.

Key Developments:

• In June 2023, Royal Philips, a worldwide pioneer in health technology, and Masimo, a global medical technology business, announced today that SedLine Brain Function Monitoring, Regional Oximetry, and CO2 readings in Philips Patient Monitors - IntelliVue MX750 and MX850 - have received FDA clearance. The latest development in Masimo and Philips' continuous partnership will assist physicians in making rapid and informed judgements without the need for extra monitoring equipment.
• In July 2022, Natus Medical Incorporated, a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced that it had been acquired by ArchiMed's MED Platform II fund, a leading investment firm focused solely on the healthcare industry. Natus stockholders received $33.50 in cash for each share of Natus common stock, according to the official merger agreement.

Company Products:

• CPAP Machines: ResMed is well-known for its continuous positive airway pressure (CPAP) devices, which are commonly used to treat obstructive sleep apnea (OSA). These devices provide a constant flow of air through a mask, keeping the airway open during sleep and preventing breathing pauses.
• Auto-CPAP (APAP) Machines: Philips Respironics offered auto-adjusting CPAP devices, which automatically alter air pressure levels based on the patient's breathing patterns during the night, assuring optimal treatment and comfort.
• Bi-Level Positive Airway Pressure (BiPAP) Machines: Drive DeVilbiss Healthcare introduced BiPAP devices, which give two separate air pressure levels during inhalation and exhalation. These devices are appropriate for people with more complicated sleep apnea disorders or requiring higher-pressure assistance.
• CPAP Masks and Accessories: BMC Medical Co., Ltd. offers a wide range of CPAP masks, including nasal masks, nasal pillows, and full-face masks, as well as accessories like as tubing, filters, and humidifiers to improve comfort and compliance during therapy.

Segmentation:

By Type Of Device

• Positive Airway Pressure (Pap) Devices
• Continuous Positive Airway Pressure (Cpap) Devices
• Bi-Level Positive Airway Pressure (Bipap) Devices
• Oral Appliances
• Adaptive Servo-Ventilation (Asv) Devices
• Oxygen Devices
• Others

By Application

• Manual
• Automatic

By End-User

• Hospitals And Sleep Clinics
• Home Care Settings
• Sleep Centers
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Sources
• 2.3. Research Design

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porters Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. HOME-BASED SLEEP APNEA DEVICES MARKET, BY TYPE OF DEVICE

• 5.1. Introduction
• 5.2. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
• 5.3. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
• 5.4. BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES
• 5.5. ORAL APPLIANCES
• 5.6. ADAPTIVE SERVO-VENTILATION (ASV) DEVICES
• 5.7. OXYGEN DEVICES
• 5.8. OTHERS

6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY APPLICATION

• 6.1. Introduction
• 6.2. MANUAL
• 6.3. AUTOMATIC

7. HOME-BASED SLEEP APNEA DEVICES MARKET, BY END-USER

• 7.1. Introduction
• 7.2. HOSPITALS AND SLEEP CLINICS
• 7.3. HOME CARE SETTINGS
• 7.4. SLEEP CENTERS
• 7.5. OTHERS
• 7.6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
• 7.7. Introduction
• 7.8. North America
  • 7.8.1. United States
  • 7.8.2. Canada
  • 7.8.3. Mexico
• 7.9. South America
  • 7.9.1. Brazil
  • 7.9.2. Argentina
  • 7.9.3. Others
• 7.10. Europe
  • 7.10.1. United Kingdom
  • 7.10.2. Germany
  • 7.10.3. France
  • 7.10.4. Italy
  • 7.10.5. Spain
  • 7.10.6. Others
• 7.11. Middle East and Africa
  • 7.11.1. Saudi Arabia
  • 7.11.2. UAE
  • 7.11.3. Others
• 7.12. Asia Pacific
  • 7.12.1. Japan
  • 7.12.2. China
  • 7.12.3. India
  • 7.12.4. South Korea
  • 7.12.5. Indonesia
  • 7.12.6. Taiwan
  • 7.12.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. RESMED INC.
• 9.2. KONINKLIJKE PHILIPS N.V.
• 9.3. FISHER & PAYKEL HEALTHCARE LIMITED
• 9.4. INVACARE CORPORATION
• 9.5. DRIVE DEVILBISS HEALTHCARE
• 9.6. BMC MEDICAL CO., LTD.
• 9.7. COMPUMEDICS LIMITED
• 9.8. NATUS MEDICAL INCORPORATED
• 9.9. NIHON KOHDEN CORPORATION
• 9.10. APEX MEDICAL CORP.